Major sponsor

Eli Lilly and Company

Eli Lilly and Company is an innovation-driven corporation committed to developing a growing portfolio of pharmaceutical products that help people live longer, healthier and more active lives.

Lilly is developing pharmaceutical products by applying the latest research from laboratories worldwide, by collaborating with eminent scientific organizations, by making use of the most up-to-date technological tools, and by providing exceptional service to our customers. Through these internal programs and external initiatives, we're seeking answers for some of the world's most urgent medical needs.

Other sponsors

Co-ordinating Commission for the Presence of Switzerland Abroad

Presence Switzerland develops and produces basic information about Switzerland under the "swissworld" label. This information is distributed to interested groups outside Switzerland with the support of Swiss representatives abroad.

The information tools primarily support Swiss representatives abroad in their information and education tasks in the field. They are also used by foreign delegations and in projects and events abroad.

John Curtin School of Medical Research

The John Curtin School is part of The Australian National University. It was created in 1948 as a result of the vision of Australian Nobel Laureate Howard Florey and Prime Minister John Curtin.

In 50 years, its scientists have made major discoveries and contributions to world health and won two of Australia's Nobel Prizes. Many other international awards have been won by ANU scientists from the John Curtin School. The School is committed to carrying out fundamental research in the sciences that underpin the practice of medicine and to bring clinically useful discoveries into application as soon as possible.

Novartis Australia

Novartis Australia is a leading provider of innovative solutions to improve health and well-being. Created in 1996 from the merger of Swiss companies, Ciba and Sandoz, Novartis has a history in Australia going back over fifty years.

Businesses include pharmaceuticals, consumer health, generics, eye-care, and animal health. Novartis employs more than 500 people across Australia, and invests over $27m annually in local research and related activity.

University of Queensland

The University of Queensland is one of Australia's premier learning and research institutions. It is the largest and oldest university in Queensland and has produced generations of graduates who have gone on to become leaders in all areas of society and industry.

The University is a founding member of the national Group of Eight, an alliance of research-strong 'sandstone' universities committed to ensuring that Australia has higher education institutions which are genuinely world class.

Australasian Society for Immunology

The aim of the Australasian Society for Immunology Incorporated is to encourage, promote and support the discipline of Immunology in the Australasian region. The ASI was created by the amalgamation in 1991 of the Australian Society for Immunology and the New Zealand Society for Immunology, providing a network for the exchange of information and for collaboration within Australia, New Zealand and overseas.

ASI members have been prominent in advancing biological and medical research world-wide. The Society seeks to encourage the study of immunology in Australia and New Zealand and is active in introducing young scientists to the discipline.

CSL Limited

CSL Limited is a global, specialty biopharmaceutical company that develops, manufactures and markets pharmaceutical products of biological origin.

CSL's Human Health business includes the operations of ZLB Behring, CSL Bioplasma and CSL Pharmaceutical, as well as our global new product development activities

Reckitt Benckiser

Reckitt Benckiser (formerly known as Reckitt and Colman) is a world leader in the manufacture and marketing of household, toiletry, food and pharmaceutical products, employing worldwide over 25,000 people. The company's brands have become internationally renowned and are sold in over 40 countries.

Reckitt Benckiser's strategy is to realise the opportunities and manage the risks that arise from the environmental aspects of our operations, to achieve continuous improvements in our environmental performance and progress towards sustainable development objectives.

Zenyth Therapeutics Limited (formerly known as AMRAD Corporation)

Zenyth Therapeutics Limited (formerly known as Amrad Corporation Limited) is an Australian biotechnology company focused on the development and commercialisation of antibody-based therapies in the areas of inflammation and cancer.

Zenyth has established a strong track record in translating basic research into commercial projects and has gained significant expertise in drug discovery, preclinical and clinical development. In addition, the Company has an extensive history of securing intellectual property associated with its projects, and negotiating substantial commercial deals with international pharmaceutical and biotechnology companies.

Bristol-Myers Squibb Pharmaceuticals

Bristol-Myers Squibb is a global pharmaceutical and related health-care products company with a mission to extend and enhance human life. Bristol-Myers Squibb is an active member of industry body Medicines Australia, and is a leader in the research, development, manufacture and marketing of innovative and ethical, high-quality medicines and health-care products,

Bristol-Myers Squibb is focusing its pharmaceutical research and development in 10 disease areas including atherosclerosis/thrombosis, cancer, diabetes, HIV/AIDS and psychiatric disorders.

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists

ASCEPT was founded in 1966 and has become the peak professional society devoted to advancing excellence in clinical and experimental pharmacology and toxicology in Australasia.

Membership is open to persons who are actively engaged in, or interested in, the pharmacological and toxicological sciences and who have appropriate qualifications. ASCEPT is affiliated to both the International Union of Pharmacology and the International Union of Toxicology.